Novoeight® is an Antihemophilic Factor (Recombinant) indicated for use in adults and children with hemophilia A for:
- Control and prevention of bleeding
- Perioperative management
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
*Novoeight is not indicated for the treatment of von Willebrand disease.
For indications, dosing and other information, please refer to the prescribing information.